191 results on '"Chao, Jason"'
Search Results
2. Quali-quanti visual methods and political bots
3. How persuasive is AI-generated propaganda?
4. Digital methods for sensory media research: Toolmaking as a critical technical practice
5. Efficacy and Safety of Iglarlixi in Hispanics and Non-Hispanic Whites with Type 2 Diabetes
6. The Potentials of Google Vision API-based Networks to Study Natively Digital Images
7. Reduced Hypoglycemia and Comparable Efficacy with Insulin Glargine 300 U/ML Versus Insulin Glargine 100 U/ML in Patients with Type 2 Diabetes Achieving Different Levels of Prebreakfast Self-Monitored Plasma Glucose
8. Insulin Glargine 300 U/Ml is Associated with Less Weight Gain while Maintaining Glycemic Control and Low Risk of Hypoglycemia Compared with Insulin Glargine 100 U/Ml in an Aging Population with Type 2 Diabetes
9. Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial
10. Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L
11. Can AI Write Persuasive Propaganda?
12. Comparing the Persuasiveness of Propaganda and GPT-3 Text
13. Relationships between Drug Company Representatives and Medical Students: Medical School Policies and Attitudes of Student Affairs Deans and Third-Year Medical Students
14. Coordinate Systems and Datum
15. Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L
16. A Complete Perspective of Nuclear Energy
17. Peer Coaching as a Technique To Foster Professional Development in Clinical Ambulatory Settings.
18. Determination of Stochastic Models of GPS Baselines in GPS Network Adjustment
19. El potencial de las redes basadas en la API Google Vision para el estudio de imágenes digitales nativas
20. Real-World Safety and Effectiveness of iGlarLixi in People With Type 2 Diabetes who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study
21. Relationships Between Drug Company Representatives and Medical Students: Medical School Policies and Attitudes of Student Affairs Deans and Third-Year Medical Students
22. Stick & Flow: a critical framework for investigating bot engagement on social media
23. Medical students' exposure to and attitudes about drug company interactions: A national survey
24. Interannual variations in the length of day and ENSO events in 1982–1983 and 1997–1998
25. Contributions of US Medical Schools to Primary Care (2003-2014): Determining and Predicting Who Really Goes Into Primary Care
26. When basal insulin is not enough: response to M Davidson
27. HBO Asia / dream raider / TV show opening sequence
28. Ultra-miniature SAW filter new structure: for 5G IoT mobile device
29. [COVID-19]-related Android (Google Play) and iOS (App Store) app ecosystems
30. Bots and the black market of social media engagement
31. The Potentials of Google Vision API-based Networks to Study Natively Digital Images.
32. Determination of Stochastic Models of GPS Baselines in GPS Network Adjustment
33. Appcestry – A Tool for the Study of Mobile Application Similarities
34. When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control
35. Choosing a Family Level Indicator of Family Function
36. BILLING CODE ACCURACY
37. Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L
38. HCFA'S NEW CODING GUIDELINES
39. Billing for Physician Services: A Comparison of Actual Billing with CPT Codes Assigned by Direct Observation
40. Illuminating the 'Black Box': A Description of 4454 Patient Visits to 138 Family Physicians
41. Family physicians' disagreements with the US Preventive Services Task Force recommendations
42. Continuing medical education software: a comparative review
43. Physician agreement with US Preventive Services Task Force recommendations
44. Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL
45. Low incidence of gastrointestinal adverse events over time with a fixed‐ratio combination of insulin glargine and lixisenatide versus lixisenatide alone
46. Glycemic Target Attainment in Insulin-Naïve Patients with T2D Receiving iGlarLixi
47. Relationship of Ethnicity to Clinical Outcomes in iGlarLixi-Treated Patients with Type 2 Diabetes
48. A1C Target Attainment in Patients with T2D Receiving iGlarLixi Who Reach PPG and FPG Targets in the Lixilan-L Trial
49. Analysis of Safety Injection Fluid Mixing in the Downcomer and Cold Leg of Pressurized Water Reactors
50. Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.